133 related articles for article (PubMed ID: 7758525)
1. Prostacyclin aerosol in an infant with pulmonary hypertension.
Santak B; Schreiber M; Kuen P; Lang D; Radermacher P
Eur J Pediatr; 1995 Mar; 154(3):233-5. PubMed ID: 7758525
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction.
Zwissler B; Welte M; Messmer K
J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):283-9. PubMed ID: 7669961
[TBL] [Abstract][Full Text] [Related]
4. PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.
Welte M; Zwissler B; Habazettl H; Messmer K
Eur Surg Res; 1993; 25(5):329-40. PubMed ID: 8404993
[TBL] [Abstract][Full Text] [Related]
5. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
[TBL] [Abstract][Full Text] [Related]
7. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension.
Turanlahti MI; Laitinen PO; Sarna SJ; Pesonen E
Heart; 1998 Feb; 79(2):169-74. PubMed ID: 9538311
[TBL] [Abstract][Full Text] [Related]
10. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.
Pepke-Zaba J; Higenbottam TW; Dinh-Xuan AT; Stone D; Wallwork J
Lancet; 1991 Nov; 338(8776):1173-4. PubMed ID: 1682593
[TBL] [Abstract][Full Text] [Related]
12. [Aerosolized prostacyclin for preoperative evaluation and post-cardiosurgical treatment of patients with pulmonary hypertension].
Schulze-Neick I; Uhlemann F; Nürnberg JH; Bültmann M; Haas NA; Dähnert I; Alexi-Meshkishvili V; Opitz C; Pappert D; Rossaint R; Kleber FX; Hetzer R; Lange PE
Z Kardiol; 1997 Feb; 86(2):71-80. PubMed ID: 9173700
[TBL] [Abstract][Full Text] [Related]
13. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
14. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Tibballs J; Goh TH; McKenzie I; Hochmann M
Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
[No Abstract] [Full Text] [Related]
15. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
Welte M; Zwissler B; Habler O; Kleen M; Messmer K
Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
Mikhail G; Gibbs J; Richardson M; Wright G; Khaghani A; Banner N; Yacoub M
Eur Heart J; 1997 Sep; 18(9):1499-504. PubMed ID: 9458458
[TBL] [Abstract][Full Text] [Related]
17. Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension.
Kinsella JP; Toews WH; Henry D; Abman SH
J Pediatr; 1993 May; 122(5 Pt 1):803-6. PubMed ID: 8496766
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations.
Goldman AP; Delius RE; Deanfield JE; Macrae DJ
Ann Thorac Surg; 1995 Aug; 60(2):300-5; discussion 306. PubMed ID: 7646090
[TBL] [Abstract][Full Text] [Related]
19. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
Van Heerden PV; Blythe D; Webb SA
Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
[TBL] [Abstract][Full Text] [Related]
20. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
De Wet CJ; Affleck DG; Jacobsohn E; Avidan MS; Tymkew H; Hill LL; Zanaboni PB; Moazami N; Smith JR
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1058-67. PubMed ID: 15052203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
